Bioextrax AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-17.71	-17.34	-21.51	-18.67	-10.53	Upgrade
Depreciation & Amortization	1.13	1.16	0.86	0.48	0.35	Upgrade
Other Operating Activities	-	-0	-	-	-	Upgrade
Change in Accounts Receivable	-10.04	-3.56	1.51	-0.73	-2.06	Upgrade
Change in Other Net Operating Assets	0.58	0.96	-4.17	1.32	3.76	Upgrade
Operating Cash Flow	-26.05	-18.78	-23.31	-17.6	-8.48	Upgrade
Capital Expenditures	-0.15	-0.22	-1.1	-6.78	-0.98	Upgrade
Investing Cash Flow	-0.15	-0.22	-1.1	-6.78	-0.98	Upgrade
Issuance of Common Stock	15.49	26.87	10.79	50.6	17.47	Upgrade
Other Financing Activities	-2.63	-4.01	-0.51	-7.67	-1.09	Upgrade
Financing Cash Flow	12.86	22.86	10.28	42.94	16.38	Upgrade
Net Cash Flow	-13.34	3.87	-14.13	18.56	6.93	Upgrade
Free Cash Flow	-26.2	-18.99	-24.41	-24.38	-9.45	Upgrade
Free Cash Flow Margin	-2001.38%	-1878.63%	-811.77%	-1109.19%	-918.56%	Upgrade
Free Cash Flow Per Share	-0.66	-0.57	-0.92	-1.44	-0.70	Upgrade
Levered Free Cash Flow	-9.28	-9.63	-16.4	-17.38	-5.5	Upgrade
Unlevered Free Cash Flow	-9.28	-9.63	-16.4	-17.38	-5.5	Upgrade
Change in Working Capital	-9.47	-2.6	-2.66	0.59	1.71	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.